Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-06-27
2006-06-27
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S233800, C514S253040, C514S301000, C514S302000, C514S305000, C544S061000, C544S127000, C544S362000, C546S114000, C546S115000, C546S116000, C546S133000
Reexamination Certificate
active
07067515
ABSTRACT:
The invention provides compounds of Formula I:where in W isThese compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful to treat diseases or conditions in which α7 is known to be involved.
REFERENCES:
patent: 4612319 (1986-09-01), King
patent: 4721720 (1988-01-01), Wootton et al.
patent: 4797406 (1989-01-01), Richardson et al.
patent: 4798829 (1989-01-01), King et al.
patent: 4803199 (1989-02-01), Donatsch et al.
patent: 4822795 (1989-04-01), King
patent: 4835162 (1989-05-01), Abood
patent: 4845092 (1989-07-01), Sanger et al.
patent: 4863919 (1989-09-01), Smith
patent: 4863921 (1989-09-01), Youssefyeh et al.
patent: 4888353 (1989-12-01), Lednicer et al.
patent: 4910193 (1990-03-01), Buchheit
patent: 4920127 (1990-04-01), King et al.
patent: 4920219 (1990-04-01), Pelletier et al.
patent: 4920227 (1990-04-01), Pelletier et al.
patent: 4921982 (1990-05-01), Cohen et al.
patent: 4924010 (1990-05-01), Youssefyeh et al.
patent: 4933445 (1990-06-01), Pelletier et al.
patent: 4935511 (1990-06-01), Youssefyeh et al.
patent: 4937247 (1990-06-01), King
patent: 4973594 (1990-11-01), Tyers
patent: 4983600 (1991-01-01), Ward et al.
patent: 4985437 (1991-01-01), Tyers
patent: 5001133 (1991-03-01), Richardson et al.
patent: 5039680 (1991-08-01), Imperato et al.
patent: 5049556 (1991-09-01), King et al.
patent: 5063231 (1991-11-01), Sanger et al.
patent: 5114947 (1992-05-01), Imondi
patent: 5175173 (1992-12-01), Sun
patent: 5183822 (1993-02-01), Van Wijngaarden et al.
patent: 5217975 (1993-06-01), Wadsworth et al.
patent: 5246942 (1993-09-01), Youssefyeh et al.
patent: 5260303 (1993-11-01), Becker et al.
patent: 5272154 (1993-12-01), Dixon et al.
patent: 5273972 (1993-12-01), Jagdmann et al.
patent: 5300512 (1994-04-01), Flynn et al.
patent: 5322951 (1994-06-01), King et al.
patent: 5342845 (1994-08-01), Chokai et al.
patent: 5352685 (1994-10-01), Maruyama et al.
patent: 5362734 (1994-11-01), Ward et al.
patent: 5362740 (1994-11-01), Bedeschi et al.
patent: 5434161 (1995-07-01), Becker
patent: 5510478 (1996-04-01), Sabb
patent: 5543426 (1996-08-01), Dixon et al.
patent: 5556851 (1996-09-01), Maruyama et al.
patent: 5561149 (1996-10-01), Azria et al.
patent: 5599937 (1997-02-01), Glas et al.
patent: 5750536 (1998-05-01), Mantovanini et al.
patent: 5977144 (1999-11-01), Meyer et al.
patent: 6054464 (2000-04-01), Macor et al.
patent: 2002/0016334 (2002-02-01), Wadsworth et al.
patent: 2003/0153595 (2003-08-01), Walker et al.
patent: 3810552 (1988-03-01), None
patent: 0030254 (1980-08-01), None
patent: 0322016 (1988-12-01), None
patent: 0457243 (1991-05-01), None
patent: 0483 836 (1991-10-01), None
patent: 0485962 (1991-11-01), None
patent: 0496064 (1991-12-01), None
patent: 0512 350 (1992-04-01), None
patent: 0635508 (1992-04-01), None
patent: 0 560 348 (1993-03-01), None
patent: 2002-30084 (2002-01-01), None
patent: WO 90/14347 (1990-05-01), None
patent: WO 91/09593 (1990-12-01), None
patent: WO 91/17161 (1991-04-01), None
patent: WO 92/10494 (1991-12-01), None
patent: WO 93/06108 (1992-09-01), None
patent: WO 9309116 (1993-05-01), None
patent: WO 95/04742 (1994-08-01), None
patent: WO 95/27490 (1995-04-01), None
patent: WO 96/33186 (1996-04-01), None
patent: WO 97/35860 (1997-03-01), None
patent: WO 99/20633 (1998-10-01), None
patent: WO 00/73431 (2000-05-01), None
patent: WO 01/36417 (2000-11-01), None
patent: WO 01/60821 (2001-02-01), None
patent: WO 01/76576 (2001-03-01), None
patent: WO 03/055878 (2003-07-01), None
patent: WO 03/078431 (2003-09-01), None
patent: WO 03/087102 (2003-10-01), None
patent: WO 03/087103 (2003-10-01), None
patent: WO 03/087104 (2003-10-01), None
Layzer, Degenerative Diseases of the Nervous System, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 2050-2057, 1996.
Damasio, Alzheimer's Disease and Relared Dementias, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1992-1996, 1996.
Bitner et al., PubMed Abstract (Brain Res 938(1-2):45-54), May 2002.
Mega, PubMed Abstract (Int J Neuropsychopharmacol, 3(7):3-12), Jul. 2000.
W.R. Kem,The brain α7 nicotine receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA(GTS-21), Behavioural Brain Research 113 (2000) pp. 169-181.
J.E.Macor, et al.The 5-HT Antagonist Tropiestron(ICS 205-930)is a Potent and Selective α7 Nicotinic Receptor Partial Agonist,Biorganic & Medicianl Chemistry Letters 11 (2001). pp. 319-321.
A Orjales, et al.,Benzimidazole-2-carboxylic acid amides and esters: a new structural class of 5-HT3 ligands,Eur. J. Med. Chem. 34(1999) pp. 415-422.
Groppi, Jr. Vincent E.
Piotrowski David W.
Reitz Steven Charles
Wishka Donn G.
Ebel Eileen M.
Pfizer Inc.
Rao Deepak
Zelson Steve T.
LandOfFree
Quinuclidines-substituted-multi-cyclic-heteroaryls for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinuclidines-substituted-multi-cyclic-heteroaryls for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinuclidines-substituted-multi-cyclic-heteroaryls for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3676103